Over the past decade, med spas, IV therapy clinics, and wellness brands have expanded at an unprecedented pace. Aesthetic medicine has become one of the fastest-growing sectors of healthcare, but rapid growth has led to increased regulatory oversight. In 2026, a new wave of California Laws will significantly reshape how Management Service Organizations (MSOs), med spas, and non-physician-owned wellness clinics operate.
California has long been known for its strict enforcement of the Corporate Practice of Medicine (CPOM) doctrine, but the 2026 updates go far beyond ownership rules. These new California Laws redefine the expectations for compliance, provider oversight, medical direction, telehealth, patient-specific orders, and the role of MSOs in clinical decision-making.
For med spas expanding rapidly into injectables, IV therapy, GLP-1 medications, peptides, and advanced wellness treatments, understanding these changes is no longer optional; it is essential.
This article breaks down the new California Laws in clear, actionable terms and explains how clinics and MSOs can stay compliant while still scaling successfully.
The 2026 California Laws are the state’s response to three mounting issues:
California regulators have documented increased complications from nonsurgical procedures, including injectables, IV drips, compounded medications, and wellness treatments administered without clear medical oversight.
California wants to eliminate the use of:
MSOs are allowed to support operations, not direct medical decisions. But many med spas unintentionally blur these lines. The new California Laws clarify these boundaries in a way that impacts almost every med spa currently operating.
The new California Laws identify and strictly separate:
Under the updated California Laws, MSOs cannot:
Violating these California Laws exposes both the MSO and the medical provider to:
These rules have existed for years, but the 2026 California Laws add teeth to enforcement with new penalties, monitoring, and reporting requirements.
Below is a breakdown of the most significant changes that will come into effect.
Following national trends, California now requires patient-specific orders for:
A Good Faith Exam (GFE) alone does not authorize treatment under the new California Laws.
This is exactly in line with the compliance shift seen in national telehealth, where platforms like Qualiphy have moved beyond GFEs toward Patient Specific Orders (PSOs) and Patient Specific Prescriptions (PSPs).
The new California Laws explicitly prohibit:
Everything must be individualized:
California has always prohibited non-physicians from owning or influencing medical practices.
But beginning in 2026, the California Laws introduce:
If an MSO violates CPOM, both the medical director and MSO leadership may be penalized.
Every med spa must now maintain:
California Laws also require confirmation that the medical director:
The most significant change in the California Laws for telehealth is clear:
Every telehealth provider serving California patients must be licensed in California.
Additional updates include:
No more “nationwide” providers doing GFEs for California care unless they hold a CA license.
California is moving toward requiring:
This reflects the national trend described in Qualiphy’s “Good Faith Exams in 2025” blog, where synchronous telehealth has become the gold standard for compliance, clinical accuracy, and patient safety.
Every clearance must produce:
Generic telehealth approvals are no longer compliant.
The 2026 California Laws introduce strict requirements around:
Clinics cannot imply that treatments:
Marketing teams will need to adjust copy, disclaimers, and funnels.
Platforms must provide:
Qualiphy’s infrastructure already follows this standard nationally, including:
California clinics will no longer be able to use:
The MSO cannot:
All medical decisions must be made exclusively by the licensed provider.
Every patient needs an individualized decision.
California regulators will now check this during routine audits.
California has announced:
This will make 2026 one of the most heavily regulated years in aesthetic medicine.
Staying compliant under the 2026 California Laws requires clinics to tighten their clinical workflows, telehealth processes, and MSO structures. While these regulations are stricter, the path to compliance is clear when broken down into a few essential steps.
California now expects meaningful clinical encounters, especially for injectables, IV therapy, GLP-1s, and peptides. Clinics should rely on synchronous (live video) telehealth or high-standard asynchronous exams reviewed by California-licensed providers. Each exam must lead to an individualized medical decision—not a template clearance.
The new California Laws prohibit generic protocols. Every treatment must now be authorized through a documented Patient-Specific Order that reflects the patient’s history, presentation, and clinical needs. This applies to injectables, IV drips, wellness treatments, and compounded medications.
California is reinforcing the Corporate Practice of Medicine. MSOs may handle operations, marketing, scheduling, and business strategy—but they cannot influence clinical decisions, treatment plans, pricing of medical services, or prescribing. Clinics should review and update MSO and medical director agreements to reflect this separation.
Only California-licensed providers may conduct telehealth exams, issue PSOs, or prescribe medications for California patients. Clinics must maintain updated provider rosters and ensure telehealth partners follow state-specific licensing rules.
Websites, funnels, and advertising must avoid clinical claims, “instant approval” language, or promises tied to medical treatments. Intake workflows should route every patient through a compliant telehealth exam before treatment is authorized.
These changes are not simply regulatory burdens; they mark a shift toward:
California is setting a model that other states will follow. The clinics that adapt now will grow rapidly, while those who ignore the laws will face:
California Laws in 2026 are not designed to slow clinics down; they are designed to create a safer, compliant, scalable foundation.
The new California Laws impacting MSOs in 2026 signify a major turning point for the med spa and wellness industry. With stricter oversight, tighter telehealth rules, required patient-specific orders, and increased CPOM enforcement, every clinic must review its operations, telehealth partners, marketing, and medical director agreements.
But with the right infrastructure and compliance-first systems in place, these laws do not need to be a barrier; they can be an opportunity. Clinics that align early will:
To stay ahead of the 2026 California Laws, clinics must adopt compliance-driven workflows, individualized medical orders, and licensed telehealth providers who meet California’s standards.
